Indivior Pharmaceuticals (INDV) FCF Margin (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted FCF Margin of 64.72% for Q2 2026, up 18.03 percentage points from 46.69% a year earlier and up 73.87 percentage points from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) FCF Margin (2024 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at Indivior Pharmaceuticals was -8.33%, down 23.07 percentage points year-over-year; for FY2025, it was -7.51%, down 8.10 percentage points from FY2024.
- Annual FCF Margin shows a four-year change of -51.63 percentage points (FY2021 to FY2025).
- In prior years, Indivior Pharmaceuticals' FCF Margin was 0.59% in FY2024 (+28.77 pp), -28.18% in FY2023 (-27.18 pp), -1.00% in FY2022 (-45.12 pp) and 44.12% in FY2021.
- The Q2 2026 figure stands as the highest quarterly FCF Margin in data going back to Q1 2024.
- On a year-over-year basis, FCF Margin increased in three of the last six quarters, with an average year-over-year change of -5.56 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was -9.15% (Q1 2026), -68.44% (Q4 2025) and -18.79% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Indivior Pharmaceuticals | 4.35 Bn | 3.32 Bn | 294.00 Mn | 64.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.72% |
| Mar 31, 2026 | -9.15% |
| Dec 31, 2025 | -68.44% |
| Sep 30, 2025 | -18.79% |
| Jun 30, 2025 | 46.69% |
| Mar 31, 2025 | 26.32% |
| Dec 31, 2024 | -11.04% |
| Sep 30, 2024 | -1.63% |
| Jun 30, 2024 | 28.09% |
| Mar 31, 2024 | -13.73% |
API Access
Indivior Pharmaceuticals FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();